{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:31:19Z","timestamp":1793323879677,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82322034"],"award-info":[{"award-number":["82322034"]}],"id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372056"],"award-info":[{"award-number":["82372056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103600"],"award-info":[{"award-number":["82103600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130083"],"award-info":[{"award-number":["82130083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172047"],"award-info":[{"award-number":["82172047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373004"],"award-info":[{"award-number":["82373004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103301"],"award-info":[{"award-number":["82103301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372596"],"award-info":[{"award-number":["82372596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515020060"],"award-info":[{"award-number":["2022B1515020060"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jhepr.2026.101977","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:26:05Z","timestamp":1785770765000},"page":"101977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined anti-PD-1 with irreversible electroporation relieves immunosuppression and reduces hepatocellular carcinoma regrowth"],"prefix":"10.1016","volume":"8","author":[{"given":"Jihui","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaomin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youmei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8921-2389","authenticated-orcid":false,"given":"Zihao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jhepr.2026.101977_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhepr.2026.101977_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2026.101977_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1148\/radiol.15141215","article-title":"Aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation: risk factors and clinical significance","volume":"276","author":"Kang","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jhepr.2026.101977_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrc3672","article-title":"Thermal ablation of tumours: biological mechanisms and advances in therapy","volume":"14","author":"Chu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2026.101977_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101977_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jso.23280","article-title":"Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures","volume":"107","author":"Cannon","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jhepr.2026.101977_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41467-019-08782-1","article-title":"Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101977_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.01.001","article-title":"Irreversible electroporation induces CD8(+) T cell immune response against post-ablation hepatocellular carcinoma growth","volume":"503","author":"Dai","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhepr.2026.101977_bib9","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1038\/s41467-021-24132-6","article-title":"Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells","volume":"12","author":"Burbach","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101977_bib10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.32585","article-title":"Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101977_bib11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/hep.32707","article-title":"Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments","volume":"77","author":"Zabransky","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101977_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2026.101977_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jhepr.2026.101977_bib14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/vaccines11061036","article-title":"Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics","volume":"11","author":"Polaj","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jhepr.2026.101977_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.scib.2025.12.017","article-title":"cGAS-STING activation mediated by FAM83H-AS1\/HMGB1 elicits NF-\u03baB-dependent immune evasion in breast cancer","volume":"71","author":"Liang","year":"2026","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.jhepr.2026.101977_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12943-024-02097-6","article-title":"YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8(+) T cell recruitment","volume":"23","author":"Yang","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jhepr.2026.101977_bib17","first-page":"6496","article-title":"Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits","volume":"63","author":"Wissniowski","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.101977_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1148\/radiol.2511072175","article-title":"Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity","volume":"251","author":"Dromi","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jhepr.2026.101977_bib19","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1158\/0008-5472.CAN-03-3949","article-title":"In situ tumor ablation creates an antigen source for the generation of antitumor immunity","volume":"64","author":"den Brok","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.101977_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1148\/radiol.2016151739","article-title":"Systemic effects of local tumor ablation: oncogenesis and antitumor induced immunity","volume":"279","author":"Mauri","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jhepr.2026.101977_bib21","article-title":"Landscape of the peripheral immune response induced by local microwave ablation in patients with breast cancer","volume":"9","author":"Zhou","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jhepr.2026.101977_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/2326-6066.CIR-22-0379","article-title":"Radiofrequency ablation remodels the tumor microenvironment and promotes neutrophil-mediated abscopal immunomodulation in pancreatic cancer","volume":"11","author":"Faraoni","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jhepr.2026.101977_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188638","article-title":"The progress of immune checkpoint therapy in primary liver cancer","volume":"1876","author":"Zheng","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jhepr.2026.101977_bib24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/hep.26153","article-title":"Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma","volume":"57","author":"Mizukoshi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101977_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/jcrt.JCRT_775_17","article-title":"Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma","volume":"14","author":"Zhou","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.jhepr.2026.101977_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2005.07.071","article-title":"Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs","volume":"335","author":"Hu","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2026.101977_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhepr.2026.101977_bib28","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","article-title":"COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells","volume":"71","author":"Fujita","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.101977_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2014.06.004","article-title":"Systemic injection of TLR1\/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice","volume":"154","author":"Zhang","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jhepr.2026.101977_bib30","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/cancers15041324","article-title":"How biology guides the combination of locoregional interventional therapies and immunotherapy for hepatocellular carcinoma: cytokines and their roles","volume":"15","author":"Fu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2026.101977_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2017.03.018","article-title":"Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer","volume":"186","author":"Lin","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jhepr.2026.101977_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00270-018-2069-y","article-title":"Safety and short-term efficacy of irreversible electroporation and allogenic natural killer cell immunotherapy combination in the treatment of patients with unresectable primary liver cancer","volume":"42","author":"Yang","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhepr.2026.101977_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","article-title":"Therapeutic targeting of tumour myeloid cells","volume":"23","author":"Barry","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2026.101977_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhepr.2026.101977_bib35","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8(+) T cells to drive T cell exhaustion and hinder autocrine IFN-gamma-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592600248X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592600248X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:34:02Z","timestamp":1793320442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592600248X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S258955592600248X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101977","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined anti-PD-1 with irreversible electroporation relieves immunosuppression and reduces hepatocellular carcinoma regrowth","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101977"}}